CC
GNMX

Casdin Capital’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History

Casdin Capital’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-375,000
Closed -$1.94M – 34
2016
Q4 		$1.94M Hold
375,000
– – 1.6% 21
2016
Q3 		$2.09M Buy
375,000
+290,000
+341% +$1.62M 1.69% 20
2016
Q2 		$472K Buy
+85,000
New +$472K 0.47% 24